1: \begin{abstract}

2: Studying the effects of groups of Single Nucleotide Polymorphisms (SNPs), as in a gene, 

3: genetic pathway, or network, can provide novel insight into complex diseases, above that 

4: which can be gleaned from studying SNPs individually. 

5: Common challenges in set-based genetic association testing include weak effect sizes,

6: correlation between SNPs in a SNP-set, and scarcity of signals, with single-SNP effects

7: often ranging from extremely sparse to moderately sparse in number.

8: Motivated by these challenges, we propose the Generalized Berk-Jones (GBJ) test for 

9: the association between a SNP-set and outcome. 

10: The GBJ extends the Berk-Jones (BJ) statistic by accounting for correlation among 

11: SNPs, and it provides advantages over the Generalized Higher Criticism (GHC) test 

12: when signals in a SNP-set are moderately sparse.  

13: We also provide an analytic p-value calculation procedure for SNP-sets of any finite size.

14: Using this p-value calculation, we illustrate that the rejection region for GBJ can be described

15: as a compromise of those for BJ and GHC.

16: We develop an omnibus statistic as well, and we show that this omnibus test is robust to 

17: the degree of signal sparsity.

18: An additional advantage of our method is the ability to conduct inference using individual 

19: SNP summary statistics from a genome-wide association study.

20: We evaluate the finite sample performance of the GBJ though simulation studies and 

21: application to gene-level association analysis of breast cancer risk.

22: \end{abstract}

23: